首页> 外文期刊>Терапевтичесκий архив >The values of cardio-ankle vascular and ankle-brachial indices in patients with carbohydrate metabolic disorders: The ESSE-RF study in the Kemerovo Region
【24h】

The values of cardio-ankle vascular and ankle-brachial indices in patients with carbohydrate metabolic disorders: The ESSE-RF study in the Kemerovo Region

机译:碳水化合物代谢紊乱患者的心踝血管和踝臂指数的值:克麦罗沃地区的ESSE-RF研究

获取原文
获取原文并翻译 | 示例
           

摘要

Aim. To investigate factors associated with pathological cardio-ankle vascular and ankle-brachial indices (CAVI and ABI) in patients with carbohydrate metabolic disorders (CMD). Subjects and methods. A cross-sectional study was conducted in the framework of the multicenter epidemiological study gEpidemiology of Cardiovascular Diseases and Their Risk Factors in the Russian Federation h (ESSE-RF) in March to October 2013. The standard ESSE-RF protocol was extended by an additional study of peripheral arterial stiffness, by estimating CAVI and ABI automatically. A sample of 1619 people was formed in several stages, in which 311 patients with type 2 diabetes mellitus and prediabetes were identified and divided into 3 groups: 1) 41 patients with pathological CAVI values (≥9.0); 2) 241 with normal CAVI (<9.0); 3) 29 with pathological ABI (<0.9). Results. In the population-based sample of patients with CMD, the pathological CAVI values (≥9.0) were detected in 14.5%, and the pathological ABI was in 9.3% of the examinees. Regression analysis showed that the pathological vascular indices (both CAVI and ABI) were significantly associated with increases in blood pressure (BP) and heart rate (HR), and a decrease in glomerular filtration rate. At the same time, only the pathological CAVI was associated with advancing age (odds ratio (OR), 1.111; 95% confidence interval (CI), 1.050-1.176; p < 0.001), visceral obesity (OR, 3.088; 95% CI, 1.001-10.495; p=0.038), smoking duration (OR, 1.093; 95% CI, 1.008-1.185; p=0.009), prior stroke (OR, 4.695; 95% CI, 1.408-15.658; p=0.018), and a need for insulin therapy (OR, 18.947; 95% CI, 1.902- 87.783; p=0.006). The pathological ABI was associated with male sex (OR, 2.227; 95% CI, 1.040-4.765; p=0.039), prior myocardial infarction (OR, 8.646; 95% CI, 2.174-34.378; p=0.005), obesity (OR, 2.439; 95% CI, 1.010-5.889; p=0.034); hyperglycemia (OR, 2.439; 95% CI, 1.010-5.889; p=0.034), hyperuricemia (OR, 4.009; 95% CI, 1.850- 8.684; p=0.033), and increases in triglyceride levels (OR, 2.984; 95% CI, 1.376-6.470; p=0.004) and CAVI (OR, 1.193; 95% CI, 1.034-1.377; p=0.005). Conclusion. The pathological vascular indices CAVI and ABI are associated with different risk factors for cardiovascular events in a cohort of patients with CMD. The common factors associated with both CAVI and ABI are increases in blood pressure and HR and a reduction in glomerular filtration rate. The common factors associated with both CAVI and ABI are increases in blood pressure and HR and a reduction in glomerular filtration rate.
机译:目标。调查与碳水化合物代谢紊乱(CMD)患者的病理性踝踝血管和踝臂指数(CAVI和ABI)相关的因素。主题和方法。 2013年3月至2013年10月,在俄罗斯联邦的多中心流行病学研究g心血管疾病流行病学及其危险因素h(ESSE-RF)的框架内进行了一项横断面研究。通过自动估计CAVI和ABI来研究外周动脉僵硬度。在不同阶段形成了1619人的样本,其中确定了311例2型糖尿病和前驱糖尿病患者,并将其分为3组:1)41例病理CAVI值(≥9.0)的患者; 2)241 CAVI(<9.0)正常; 3)29具病理性ABI(<0.9)。结果。在以人群为基础的CMD患者样本中,被检者的病理CAVI值(≥9.0)占14.5%,而被检者的ABI占9.3%。回归分析显示,病理性血管指数(CAVI和ABI)与血压(BP)和心率(HR)升高以及肾小球滤过率降低显着相关。同时,只有病理性CAVI与年龄增长相关(优势比(OR)为1.111; 95%置信区间(CI)为1.050-1.176; p <0.001),内脏肥胖症(OR为3.088; 95%CI ,1.001-10.495; p = 0.038),吸烟时间(OR,1.093; 95%CI,1.008-1.185; p = 0.009),先前卒中(OR,4.695; 95%CI,1.408-15.658; p = 0.018),并且需要胰岛素治疗(OR,18.947; 95%CI,1.902-87.783; p = 0.006)。病理性ABI与男性(OR,2.227; 95%CI,1.040-4.765; p = 0.039),先前的心肌梗塞(OR,8.646; 95%CI,2.174-34.378; p = 0.005),肥胖症(OR ,2.439; 95%CI,1.010-5.889; p = 0.034);高血糖症(OR,2.439; 95%CI,1.010-5.889; p = 0.034),高尿酸血症(OR,4.009; 95%CI,1.850-8.884; p = 0.033)和甘油三酸酯水平升高(OR,2.984; 95% CI,1.376-6.470; p = 0.004)和CAVI(OR,1.193; 95%CI,1.034-1.377; p = 0.005)。结论。一组CMD患者的病理血管指数CAVI和ABI与心血管事件的不同危险因素相关。与CAVI和ABI相关的共同因素是血压和HR升高以及肾小球滤过率降低。与CAVI和ABI相关的共同因素是血压和HR升高以及肾小球滤过率降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号